Skinvisible, Inc. Net Change in Cash
Skinvisible, Inc. (SKVI) reported Net Change in Cash of $1.34 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-13
- Skinvisible, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was -$822.00, a 126.86% decline year-over-year.
- Skinvisible, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $3.06K, a 57.55% decline year-over-year.
- Skinvisible, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $7.21K.
- Skinvisible, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$52.24K.
- Skinvisible, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$7.72K, a 181.67% decline from fiscal 2024.
- Skinvisible, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $9.45K.
- Skinvisible, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$80.49K, a 624.67% decline from fiscal 2022.
- Skinvisible, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was $15.34K, a 49.10% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.34K 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | -$822.00 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | -$7.72K 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -$9.69K 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | -$10.22K 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | $3.06K 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | $9.45K 10-K · filed 2026-03-31 | |||
| 2024-09-30 | -$276.00 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $6.10K 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | $7.21K 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | -$80.49K 10-K · filed 2025-04-14 | |||
| 2023-09-30 | -$80.65K 10-Q · filed 2024-11-19 | |||
| 2023-06-30 | -$77.83K 10-Q · filed 2024-08-15 | |||
| 2023-03-31 | -$52.24K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $15.34K 10-K · filed 2024-04-16 | |||
| 2022-09-30 | $61.38K 10-Q · filed 2023-11-15 | |||
| 2022-06-30 | $94.30K 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | -$40.94K 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $30.14K 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $13.33K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $19.08K 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | -$23.23K 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $34.60K 10-K · filed 2022-03-31 | |||
| 2020-09-30 | $10.52K 10-Q · filed 2021-11-19 | |||
| 2020-06-30 | $33.79K 10-Q · filed 2021-08-16 |